Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-09

Clinical Trial Update: SHARPEN - Parkinson's Disease Dementia [NA]

View source ↗

Summary

The SHARPEN trial for Parkinson disease dementia has been terminated and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Scion NeuroStim | Conditions: Parkinson Disease Dementia | NA | Status: TERMINATED | Results posted: 2025-05-09